Q13113 (PDZ1I_HUMAN) Homo sapiens (Human)
PDZK1-interacting protein 1 UniProtKBInterProSTRINGInteractive Modelling
114 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
10 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of human SGLT1-MAP17 complex bound with LX2761 |
Heteromer P13866; | 1×1YI; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex bound with empagliflozin |
Heteromer P31639; | 2×PLM; 1×7R3; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex with Dapagliflozin |
Heteromer P31639; | 1×NAG; 1×LE6; 1×NA; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex with TA1887 |
Heteromer P31639; | 1×NAG; 1×KZ3; 1×NA; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex with Canagliflozin |
Heteromer P31639; | 1×NAG; 1×L3R; 1×NA; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex with Sotagliflozin |
Heteromer P31639; | 1×NAG; 1×LFL; 1×NA; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex with Phlorizin |
Heteromer P31639; | 1×NAG; 1×LN9; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex bound with substrate AMG in the occluded conformation |
Heteromer P31639; | 1×GYP; | ||||
| Assess | ||||||
| Structure of human SGLT1-MAP17 complex bound with substrate 4D4FDG in the occluded conformation |
Heteromer P13866; | 1×KQC; | ||||
| Assess | ||||||
| Structure of human SGLT2-MAP17 complex in the apo state in the inward-facing conformation |
Heteromer P31639; | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7wmv.1.B | monomer | 0.75 | 99.12 | |||
| Assess | ||||||